Olanzapine Plus Fosaprepitant Standard Antiemetic Therapy in the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients Receiving High Emetic Risk Multi-day Chemotherapy: a Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study
Clinical trial NCT04536558 · UNKNOWN
Trial details
- NCT number
- NCT04536558
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-01
- Primary completion
- 2021-02-01
- Enrollment
- 352
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.